价格

DHODH 2

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

DOSAGE REGIMEN OF VIDOFLUDIMUS FOR USE IN THE TREATMENT OF CHRONIC INFLAMMATORY AND/OR AUTOIMMUNE DISEASES
EP 3713554 B1申请人: IMMUNIC AG优先权: 2017
CN
EP
US
WO
9 件公开
METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE
- EP 4782436 A2
  申请人: OHIO STATE INNOVATION FOUNDATION优先权: 2019
  CN
  EP
  US
  WO
  5 件公开
- EP 4438042 A3
  申请人: OHIO STATE INNOVATION FOUNDATION优先权: 2018
  CN
  EP
  US
  4 件公开
- WO 2025227007 A1
  申请人: OHIO STATE INNOVATION FOUNDATION优先权: 2024
  WO
Calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-proliferative agents
US 12037305 B2申请人: IMMUNIC AG优先权: 2018
CN
EP
US
4 件公开
VIDOFLUDIMUS FOR USE IN THE TREATMENT OR PREVENTION OF VIRAL DISEASES
EP 4487870 A3申请人: IMMUNIC AG优先权: 2020
CN
EP
US
4 件公开
HETEROAROMATIC DHODH INHIBITORS
EP 4735426 A1申请人: IMMUNIC AG优先权: 2023
CN
EP
WO
3 件公开
SODIUM SALT OF 5-CYCLOPROPYL-2-BENZOIC ACID AS DHODH INHIBITOR
US 2012003184 A1申请人: GARCIA GONZALEZ NURIA优先权: 2009
EP
US
3 件公开
Compounds and methods useful for treating or preventing hematological cancers
US 11096934 B2申请人: BROAD INST INC优先权: 2015
CN
US
3 件公开
COMPOSITIONS FOR USE FOR THE INHIBITION OF DIHYDROOROTATE DEHYDROGENASE
EP 4081512 A1申请人: OHIO STATE INNOVATION FOUNDATION优先权: 2019
EP
US
3 件公开
Method of identifying inhibitors of DHODH
US 7247736 B2申请人: 4SC AG优先权: 2004
US
3 件公开
Compositions and methods for inhibiting dihydroorotate dehydrogenase
US 10889548 B2申请人: CLEAR CREEK BIO INC优先权: 2019
US
3 件公开

药物

DHODH 2

专利

METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE